ICU Medical, Inc. (NASDAQ:ICUI) Receives Average Recommendation of “Moderate Buy” from Analysts

ICU Medical, Inc. (NASDAQ:ICUI) has received a consensus rating of “Moderate Buy” from the four ratings firms that are presently covering the company, Marketbeat reports. One research analyst has rated the stock with a hold rating and three have issued a buy rating on the company. The average 12-month price target among brokers that have issued ratings on the stock in the last year is $149.00.

Several equities analysts recently issued reports on the stock. Raymond James boosted their target price on shares of ICU Medical from $158.00 to $190.00 and gave the company an “outperform” rating in a report on Thursday, September 12th. Needham & Company LLC restated a “hold” rating on shares of ICU Medical in a research report on Thursday, August 8th. KeyCorp lifted their target price on ICU Medical from $136.00 to $147.00 and gave the stock an “overweight” rating in a report on Thursday, August 8th. Finally, StockNews.com upgraded ICU Medical from a “hold” rating to a “buy” rating in a report on Thursday, September 12th.

Insider Activity

In other ICU Medical news, VP Virginia Ruth Sanzone sold 2,050 shares of the stock in a transaction that occurred on Thursday, August 8th. The stock was sold at an average price of $144.11, for a total value of $295,425.50. Following the transaction, the vice president now owns 4,482 shares in the company, valued at $645,901.02. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In other news, CEO Vivek Jain sold 12,000 shares of the business’s stock in a transaction dated Friday, August 16th. The shares were sold at an average price of $156.04, for a total transaction of $1,872,480.00. Following the completion of the sale, the chief executive officer now directly owns 104,593 shares of the company’s stock, valued at $16,320,691.72. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, VP Virginia Ruth Sanzone sold 2,050 shares of the firm’s stock in a transaction dated Thursday, August 8th. The shares were sold at an average price of $144.11, for a total transaction of $295,425.50. Following the completion of the transaction, the vice president now directly owns 4,482 shares in the company, valued at approximately $645,901.02. The disclosure for this sale can be found here. Insiders sold a total of 28,552 shares of company stock worth $4,537,802 in the last three months. Company insiders own 6.70% of the company’s stock.

Institutional Trading of ICU Medical

Several institutional investors and hedge funds have recently modified their holdings of ICUI. Vanguard Group Inc. boosted its position in shares of ICU Medical by 0.5% during the first quarter. Vanguard Group Inc. now owns 2,452,720 shares of the medical instruments supplier’s stock valued at $263,226,000 after buying an additional 11,991 shares during the last quarter. Schroder Investment Management Group boosted its holdings in ICU Medical by 35.8% during the 4th quarter. Schroder Investment Management Group now owns 433,852 shares of the medical instruments supplier’s stock worth $43,272,000 after acquiring an additional 114,344 shares during the last quarter. Dimensional Fund Advisors LP grew its stake in shares of ICU Medical by 21.7% in the 2nd quarter. Dimensional Fund Advisors LP now owns 311,542 shares of the medical instruments supplier’s stock worth $36,996,000 after acquiring an additional 55,588 shares in the last quarter. Silvercrest Asset Management Group LLC raised its holdings in shares of ICU Medical by 109.4% in the first quarter. Silvercrest Asset Management Group LLC now owns 278,436 shares of the medical instruments supplier’s stock valued at $29,882,000 after purchasing an additional 145,485 shares during the last quarter. Finally, Bank of New York Mellon Corp lifted its position in shares of ICU Medical by 11.5% during the second quarter. Bank of New York Mellon Corp now owns 216,509 shares of the medical instruments supplier’s stock valued at $25,710,000 after purchasing an additional 22,310 shares in the last quarter. 96.10% of the stock is owned by hedge funds and other institutional investors.

ICU Medical Trading Down 0.0 %

Shares of NASDAQ ICUI opened at $174.47 on Friday. The firm has a 50 day moving average price of $154.77 and a two-hundred day moving average price of $124.01. The stock has a market cap of $4.25 billion, a P/E ratio of -71.21 and a beta of 0.65. ICU Medical has a 52-week low of $78.28 and a 52-week high of $181.87. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.08 and a current ratio of 2.41.

ICU Medical (NASDAQ:ICUI) last posted its quarterly earnings data on Wednesday, August 7th. The medical instruments supplier reported $1.56 earnings per share for the quarter, beating analysts’ consensus estimates of $1.00 by $0.56. The business had revenue of $596.50 million during the quarter, compared to the consensus estimate of $556.64 million. ICU Medical had a positive return on equity of 5.01% and a negative net margin of 3.07%. ICU Medical’s quarterly revenue was up 8.6% on a year-over-year basis. During the same period in the prior year, the business posted $1.58 earnings per share. As a group, equities analysts forecast that ICU Medical will post 3.76 EPS for the current year.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.